Historically, hemostasis has been divided into three parts: (1) blood vessel constriction, (2) primary hemostasis resulting in a platelet plug, and (3) plasmatic-based blood coagulation. However, in ...

BIVIGAM (immune globulin intravenous [human] 10% liquid) Biotest Pharmaceuticals announced that the FDA has approved Bivigam (immune globulin intravenous [human], 10%) liquid with a validated assay ...

Measuring thrombin generation can identify patients who are at low risk for recurrent venous thromboembolism (VTE), according to a recent study. Such a classification could help physicians decide who ...

DEERFIELD, Ill.--(BUSINESS WIRE)--April 4, 2005--Dade Behring Inc. (NASDAQ:DADE), the global market leader in hemostasis diagnostics, today announced that their Endogenous Thrombin Potential (ETP) ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Life science researchers who want to expand their capabilities beyond traditional cell counting instruments can now do so with the Countess II FL, a next-generation, ...

Although acute severe ulcerative colitis (ASUC) is recognized as a life-threatening flare associated with elevated thrombotic risk, the extent and duration of hypercoagulability after hospital ...

SOUTH SAN FRANCISCO, Calif., July 8, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced new in vitro data establishing the relationship between concentrations of the ...

LACHEN, Switzerland--(BUSINESS WIRE)-- On 30 May 2011 The European Commission adopted the EMA's recommendation of 14 April 2011 revised on May 12, 2011 to lift the suspension of the marketing ...